Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Accelerate Diagnosti (AXDX)

Accelerate Diagnosti (AXDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,154
  • Shares Outstanding, K 22,051
  • Annual Sales, $ 12,060 K
  • Annual Income, $ -61,620 K
  • 60-Month Beta 0.53
  • Price/Sales 1.60
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AXDX with:

Options Overview Details

View History
  • Implied Volatility 355.73% ( +133.04%)
  • Historical Volatility 90.98%
  • IV Percentile 72%
  • IV Rank 25.70%
  • IV High 1,366.64% on 06/14/23
  • IV Low 6.08% on 12/12/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.79
  • Today's Open Interest 609
  • Open Int (30-Day) 554

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.55
  • Number of Estimates 1
  • High Estimate -0.55
  • Low Estimate -0.55
  • Prior Year -2.36
  • Growth Rate Est. (year over year) +76.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8341 +22.32%
on 05/09/24
1.1300 -9.71%
on 05/21/24
+0.0703 (+7.40%)
since 04/23/24
3-Month
0.7300 +39.77%
on 04/18/24
1.1900 -14.26%
on 03/11/24
+0.0503 (+5.19%)
since 02/23/24
52-Week
0.7300 +39.77%
on 04/18/24
11.9000 -91.43%
on 06/12/23
-6.3397 (-86.14%)
since 05/23/23

Most Recent Stories

More News
Accelerate Diagnostics: Q1 Earnings Snapshot

Accelerate Diagnostics: Q1 Earnings Snapshot

AXDX : 1.0203 (-2.83%)
Accelerate Diagnostics: Q3 Earnings Snapshot

Accelerate Diagnostics: Q3 Earnings Snapshot

AXDX : 1.0203 (-2.83%)
Accelerate Diagnostics: Q2 Earnings Snapshot

Accelerate Diagnostics: Q2 Earnings Snapshot

AXDX : 1.0203 (-2.83%)
Accelerate Diagnostics Reports Second Quarter 2023 Financial Results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June 30, 2023....

AXDX : 1.0203 (-2.83%)
Accelerate Diagnostics Scheduled Call to Review 2023 Second Quarter Results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Thursday, August 10, 2023, at 4:30 p....

AXDX : 1.0203 (-2.83%)
Accelerate Diagnostics: Q1 Earnings Snapshot

Accelerate Diagnostics: Q1 Earnings Snapshot

AXDX : 1.0203 (-2.83%)
Accelerate Diagnostics Reports First Quarter 2023 Financial Results

/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2023. "Our...

AXDX : 1.0203 (-2.83%)
Syneos Health (SYNH) Announces a $7.1 Billion Merger Agreement

Syneos Health (SYNH) is set to become private company following a $7.1 billion merger deal to be acquired by a private investment consortium.

SYNH : 42.98 (+0.02%)
AXDX : 1.0203 (-2.83%)
PEN : 193.61 (-2.69%)
SIBN : 13.72 (-2.21%)
Walgreens Boots (WBA) New Alliances Aid Growth, Cost Woe Stays

Intensifying competition in the U.S. pharmacy retail drugstore market compels Walgreens Boots (WBA) to diversify its product offerings through new partnerships.

WBA : 16.20 (-1.64%)
AXDX : 1.0203 (-2.83%)
PEN : 193.61 (-2.69%)
SIBN : 13.72 (-2.21%)
Penumbra (PEN) Hits 52-Week High: What's Driving the Rise?

Penumbra (PEN) outperforms the industry and the S&P 500, backed by investors' optimism about the recently released first-quarter 2023 results.

PEN : 193.61 (-2.69%)
OMI : 17.42 (-1.91%)
AXDX : 1.0203 (-2.83%)
SIBN : 13.72 (-2.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections...

See More

Key Turning Points

3rd Resistance Point 1.1933
2nd Resistance Point 1.1367
1st Resistance Point 1.0933
Last Price 1.0203
1st Support Level 0.9933
2nd Support Level 0.9367
3rd Support Level 0.8933

See More

52-Week High 11.9000
Fibonacci 61.8% 7.6331
Fibonacci 50% 6.3150
Fibonacci 38.2% 4.9969
Last Price 1.0203
52-Week Low 0.7300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar